mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.8 |